Redefining the treatment of Chagas disease: a review of recent clinical and pharmacological data for a novel formulation of nifurtimox.
Nifurtimox has been used for over 50 years to treat patients with Chagas disease, a potentially life-threatening neglected tropical disease caused by the protozoan parasite Trypanosoma cruzi. Without effective antitrypanosomal treatment, the infection can persist and progress to a chronic, often deb...
Saved in:
| Main Authors: | Jaime Altcheh, Ulrike Grossmann, Heino Stass, Martin Springsklee, Facundo Garcia-Bournissen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-02-01
|
| Series: | PLoS Neglected Tropical Diseases |
| Online Access: | https://doi.org/10.1371/journal.pntd.0012849 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Negligible exposure to nifurtimox through breast milk during maternal treatment for Chagas Disease.
by: Samanta Moroni, et al.
Published: (2019-08-01) -
Development and Characterization of Innovative Nifurtimox Formulations as Therapeutic Alternative for Chagas Disease
by: Ana Lia Mazzeti, et al.
Published: (2025-02-01) -
Longitudinal follow up of serological response in children treated for Chagas disease.
by: Guillermo Moscatelli, et al.
Published: (2019-08-01) -
Impact of migration on the occurrence of new cases of Chagas disease in Buenos Aires city, Argentina
by: Guillermo Moscatelli, et al.
Published: (2013-08-01) -
Follow-up of an asymptomatic Chagas disease population of children after treatment with nifurtimox (Lampit) in a sylvatic endemic transmission area of Colombia.
by: Fiorella Bianchi, et al.
Published: (2015-02-01)